Royal Bank Of Canada Acasti Pharma Inc. Transaction History

Royal Bank Of Canada

  • $425 Billion
  • Q2 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.43 - $0.81 $775 - $1,461
1,804 Added 105.74%
3,510 $1,000
Q4 2022

Feb 14, 2023
BUY
$0.34 - $3.78 $205 - $2,286
605 Added 54.95%
1,706 $0
Q3 2022

Nov 14, 2022
BUY
$0.62 - $3.66 $437 - $2,583
706 Added 178.73%
1,101 $1,000
Q2 2022

Aug 15, 2022
BUY
$0.85 - $1.29 $142 - $216
168 Added 74.01%
395 $0
Q1 2022

May 16, 2022
SELL
$0.94 - $1.43 $1,767 - $2,688
-1,880 Reduced 89.23%
227 $0
Q4 2021

Feb 14, 2022
BUY
$1.07 - $2.01 $1,232 - $2,315
1,152 Added 120.63%
2,107 $3,000
Q3 2021

Nov 15, 2021
BUY
$1.96 - $4.72 $1,871 - $4,507
955 New
955 $2,000

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $145M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email